Malnutrition, Cancer Stage and Gastrostomy Timing as Markers of Poor Outcomes in Gastrostomy-Fed Head and Neck Cancer Patients
Nutrients · 2023
DOI: 10.3390/nu15030662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Diogo Sousa-Catita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Patologia Médica, Nutrição e Exercício Clínico (PaMNEC) do Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), 2829-511 Almada, Port…. Hauptthemen laut MEDLINE: Malnutrition, Head and Neck Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege, Mangelernährung
Abstract (Originalsprache)
For percutaneous endoscopic gastrostomy (PEG)-fed head and neck cancer (HNC) patients, risk markers of poor outcomes may identify those needing more intensive support. This retrospective study aimed to evaluate markers of poor outcomes using TNM-defined stages, initial anthropometry [body mass index (BMI), mid-upper arm circumference (MUAC), tricipital skinfold (TSF), mid-arm muscle circumference (MAMC)] and laboratory data (albumin, transferrin, cholesterol), with 138 patients, 42–94 years old, enrolled. The patients had cancer, most frequently in the larynx (n = 52), predominantly stage IV (n = 109). Stage IVc presented a four times greater death risk than stage I (OR 3.998). Most patients presented low parameters: low BMI (n = 76), MUAC (n = 114), TSF (n = 58), MAMC (n = 81), albumin (n = 47), transferrin (n = 93), and cholesterol (n = 53). In stages I, III, IVa, and IVb, MAMC and PEG-timing were major survival determinants. Each MAMC unit increase resulted in 16% death risk decrease. Additional 10 PEG-feeding days resulted in 1% mortality decrease. Comparing IVa/IVb vs. IVc, albumin and transferrin presented significant differences (p = 0.042; p = 0.008). All parameters decreased as severity of stages increased. HNC patients were malnourished before PEG, with advanced cancer stages, and poor outcomes. Initial MAMC, reflecting lean tissue, significantly increases survival time, highlighting the importance of preserving muscle mass. PEG duration correlated positively with increased survival, lowering death risk by 1% for every additional 10 PEG-feeding days, signaling the need for early gastrostomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grupo de Patologia Médica, Nutrição e Exercício Clínico (PaMNEC) do Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), 2829-511 Almada, Portugal.
- GENE-Artificial Feeding Team, Gastroenterology Department, Hospital Garcia de Orta, 2805-267 Almada, Portugal.
- Residências Montepio-Serviços de Saúde, SA-Rua Julieta Ferrão Nº 10-5º, 1600-131 Lisboa, Portugal.
- Otorhinolaryngology Department, Hospital Garcia de Orta, 2805-267 Almada, Portugal.
ORCID-Profile: Diogo Sousa-Catita, Paulo Mascarenhas, Carla Adriana Santos, Catarina Godinho, Jorge Fonseca
Zitieren
APA
Sousa-Catita, D., Ferreira-Santos, C., Mascarenhas, P., Oliveira, C., Madeira, R., Santos, C. A., André, C., Godinho, C., Antunes, L., & Fonseca, J. (2023). Malnutrition, Cancer Stage and Gastrostomy Timing as Markers of Poor Outcomes in Gastrostomy-Fed Head and Neck Cancer Patients. Nutrients. https://doi.org/10.3390/nu15030662
Vancouver
Sousa-Catita D, Ferreira-Santos C, Mascarenhas P, Oliveira C, Madeira R, Santos CA, et al. Malnutrition, Cancer Stage and Gastrostomy Timing as Markers of Poor Outcomes in Gastrostomy-Fed Head and Neck Cancer Patients. Nutrients. 2023. doi:10.3390/nu15030662
BibTeX
@article{SousaCatita2023,
author = {Sousa-Catita, Diogo and Ferreira-Santos, Cláudia and Mascarenhas, Paulo and Oliveira, Cátia and Madeira, Raquel and Santos, Carla Adriana and André, Carla and Godinho, Catarina and Antunes, Luís and Fonseca, Jorge},
title = {Malnutrition, Cancer Stage and Gastrostomy Timing as Markers of Poor Outcomes in Gastrostomy-Fed Head and Neck Cancer Patients},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15030662}
}
EUVIMED